Back to search

Article

Early Mucosal Type II Interferon Limits SARS-CoV-2 Replication in Humans

2026-07-01

Abstract excerpt

<h4>ABSTRACT</h4> COVID-19 vaccines markedly reduce disease severity, but their ability to block infection and transmission remains limited and variable. 1 A better understanding of early mucosal immune programs that constrain viral replication at susceptible upper respiratory sites is needed to develop more effective antiviral strategies. However, temporal and anatomical antiviral dynamics are difficult to reso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
305608c1-e983-5249-a28e-89715c85a92d
DOI
10.64898/2026.06.29.26356894
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early Mucosal Type II Interferon Limits SARS-CoV-2 Replication in HumansDOI 10.64898/2026.06.29.26356894
Select a neighboring publication to make it the new centre.